Kopran has informed that a Meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider approve and take on record the audited financial results of the Company for the Fourth Quarter and Year ended March 31, 2016, the audited Consolidated Financial Results of the Company and its subsidiaries for the Fourth Quarter and Year ended March 31, 2016. Further, the Trading Window in respect of Company’s Securities shall remain closed for all the Directors /Officers/ Designated Employees of the Company from the opening of the trading hours on May 26, 2016 till the close of the trading hours on June 01, 2016 as per the Code of Conduct for Prohibition of Insider Trading.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: